Prevalence of undiagnosed pernicious anemia in the elderly

Archives of Internal Medicine

Volumn 156, Issue 10, 1996, Pages 1097-1100

  Carmel, Ralph ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; INTRINSIC FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERNICIOUS ANEMIA; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES;

AGED; AGED, 80 AND OVER; ANEMIA, PERNICIOUS; ANTIBODIES; FEMALE; HUMANS; INTRINSIC FACTOR; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; VITAMIN B 12;

EID: 0029891583     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.10.1097     Document Type: Article

References (22)

1. Chanarin I. The Megaloblastic Anaemias. 2nd ed. Boston, Mass: Blackwell Scientific Publications Inc; 1979.
2. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morbid Mortal Wkly Rep. 1992;41(RR-14):1-7.
3. Willett WC. Folic acid and neural tube defect: can't we come to closure? Am J Public Health. 1992;82:666-668.
4. Rosenberg IH. Folic acid and neural-tube defects: time for action? N Engl J Med. 1992;327:1875-1877.
5. Wald N, Folic acid and the prevention of neural tube defects. Ann N Y Acad Sci. 1993;678:112-129.
6. Mills JL, Raymond E. Effects of recent research on recommendations for periconceptional folate supplement use. Ann N Y Acad Sci. 1993;678:137-145.
7. Rush D. Periconceptional folate and neural tube defect. Am J Clin Nutr. 1994; 59(suppl):511S-516S.
8. Carmel R, Karnaze DS, Weiner JM. Neurological abnormalities in cobalamin deficiency are associated with higher cobalamin 'analogue' values than are hematological abnormalities. J Lab Clin Med. 1988;111:57-62.
9. Nimo RE, Carmel R. Increased sensitivity of detection of the blocking (type I) anti-intrinsic factor antibody. Am J Clin Pathol. 1987;88:729-733.
10. Roitt IM, Doniach D, Shapland C. Autoimmunity in pernicious anemia and atrophic gastritis. Ann N Y Acad Sci. 1965;124:644-656.
11. Rothenberg SP, Kantha KRK, Ficarra A. Autoantibodies to intrinsic factor: their determination and clinical usefulness. J Lab Clin Med. 1971;77:476-484.
12. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: Influence of patient age and race. Clin Exp Immmunol. 1992;89:74-77.
13. Carmel R. Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol. 1988;90:442-446.
14. Walsh JH, Grossman MI. Gastrin. N Engl J Med. 1975;292:1377-1384.
15. Carmel R, Gott PS, Waters CH, et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electropnysiologic abnormalities, Eur J Haematol. 1995;54:245-253.
16. Carmel R, Johnson CS, Weiner JM. Pernicious anemia in Latin Americans is not a disease of the elderly. Arch Intern Med. 1987;147:1995-1996.
17. National Center for Health Statistics. Advanced report of final natality statistics. Monthly Vital Statistics Report. 1990;44(No. 9): Suppl.
18. United States Population Estimates by Age, Sex, Race and Origin, 1990-1994. Washington, DC: US Bureau of the Census; Population Division Release PPL-21.
19. Carmel R, Johnson CS. Racial patterns in pernicious anemia: early age of onset and increased frequency of intrinsic factor antibody in black women. N Engl J Med. 1978;298:647-650.
20. Carmel R. Macrocytosis, mild anemia, and delay in diagnosis of pernicious anemia. Arch Intern Med. 1979;139:47-50.
21. 12 deficiency. Can Med Assoc J. 1980;123:1127-1130.
22. Carmel R, Karnaze DS. Physician response to low serum cobalamin levels. Arch Intern Med. 1986;146:1161-1165.